Cover Image
市場調查報告書

腦內出血; 開發平台評估

Intracerebral Hemorrhage - Pipeline Review, H2 2014

出版商 Global Markets Direct 商品編碼 319633
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
腦內出血; 開發平台評估 Intracerebral Hemorrhage - Pipeline Review, H2 2014
出版日期: 2014年11月18日 內容資訊: 英文 38 Pages
簡介

腦內出血(ICH)是血液突然流入腦組織時引發的,會帶給腦部損傷,出現類似腦中風的症狀。症狀有強烈的頭痛、吞嚥困難、一眼或雙眼的視覺障礙、喪失平衡和運動感、眩暈、噁心、精神混亂等。風險要素有身體的外傷、腫瘤的出血、血友病和鐮狀細胞貧血症等出血性疾病。

本報告提供腦內出血的治療藥開發平台現狀及最新更新的各開發階段比較分析,提供您加上企業和研究機關最新新聞和發表的企業和研究機關開發的治療藥,治療藥的評估,後期階段及中止的計劃等相關資訊等。

簡介

  • 調查範圍

腦內出血 概要

治療藥的開發

  • 開發中產品;概要
  • 開發中產品;比較分析

企業開發中的治療藥

開發中產品概況

  • 後期階段的產品
  • 臨床階段的產品
  • 初期階段的產品

企業開發中的產品

治療藥的開發企業

  • ActiveSite Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd.
  • MediPost Co., Ltd.
  • Pfizer Inc.

治療藥的評估

  • 單劑產品
  • 標的別
  • 各作用機制
  • 各給藥途徑
  • 各分子類型

藥物簡介

  • alteplase
  • ASP-440
  • PF-05230907
  • Pneumostem
  • Stem Cell Therapy for Cerebral Hemorrhage

最近的開發平台趨勢

暫停中的計劃

開發中止的產品

附錄

圖表

目錄
Product Code: GMDHC5731IDB

Summary

Global Markets Direct's, 'Intracerebral Hemorrhage - Pipeline Review, H2 2014', provides an overview of the Intracerebral Hemorrhage's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Intracerebral Hemorrhage, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Intracerebral Hemorrhage and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Intracerebral Hemorrhage
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Intracerebral Hemorrhage and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Intracerebral Hemorrhage products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Intracerebral Hemorrhage pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Intracerebral Hemorrhage
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Intracerebral Hemorrhage pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Intracerebral Hemorrhage Overview
  • Therapeutics Development
    • Pipeline Products for Intracerebral Hemorrhage - Overview
    • Pipeline Products for Intracerebral Hemorrhage - Comparative Analysis
  • Intracerebral Hemorrhage - Therapeutics under Development by Companies
  • Intracerebral Hemorrhage - Pipeline Products Glance
    • Late Stage Products
    • Clinical Stage Products
    • Early Stage Products
  • Intracerebral Hemorrhage - Products under Development by Companies
  • Intracerebral Hemorrhage - Companies Involved in Therapeutics Development
    • ActiveSite Pharmaceuticals, Inc.
    • F. Hoffmann-La Roche Ltd.
    • MediPost Co., Ltd.
    • Pfizer Inc.
  • Intracerebral Hemorrhage - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Route of Administration
    • Assessment by Molecule Type
  • Drug Profiles
    • alteplase - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ASP-440 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PF-05230907 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Pneumostem - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Stem Cell Therapy for Cerebral Hemorrhage - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Intracerebral Hemorrhage - Recent Pipeline Updates
  • Intracerebral Hemorrhage - Dormant Projects
  • Intracerebral Hemorrhage - Discontinued Products
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Intracerebral Hemorrhage, H2 2014
  • Number of Products under Development for Intracerebral Hemorrhage - Comparative Analysis, H2 2014
  • Number of Products under Development by Companies, H2 2014
  • Comparative Analysis by Late Stage Development, H2 2014
  • Comparative Analysis by Clinical Stage Development, H2 2014
  • Comparative Analysis by Early Stage Development, H2 2014
  • Products under Development by Companies, H2 2014
  • Intracerebral Hemorrhage - Pipeline by ActiveSite Pharmaceuticals, Inc., H2 2014
  • Intracerebral Hemorrhage - Pipeline by F. Hoffmann-La Roche Ltd., H2 2014
  • Intracerebral Hemorrhage - Pipeline by MediPost Co., Ltd., H2 2014
  • Intracerebral Hemorrhage - Pipeline by Pfizer Inc., H2 2014
  • Assessment by Monotherapy Products, H2 2014
  • Number of Products by Stage and Target, H2 2014
  • Number of Products by Stage and Mechanism of Action, H2 2014
  • Number of Products by Stage and Route of Administration, H2 2014
  • Number of Products by Stage and Molecule Type, H2 2014
  • Intracerebral Hemorrhage Therapeutics - Recent Pipeline Updates, H2 2014
  • Intracerebral Hemorrhage - Dormant Projects, H2 2014
  • Intracerebral Hemorrhage - Discontinued Products, H2 2014

List of Figures

  • Number of Products under Development for Intracerebral Hemorrhage, H2 2014
  • Number of Products under Development for Intracerebral Hemorrhage - Comparative Analysis, H2 2014
  • Number of Products under Development by Companies, H2 2014
  • Assessment by Monotherapy Products, H2 2014
  • Number of Products by Top 10 Targets, H2 2014
  • Number of Products by Stage and Top 10 Targets, H2 2014
  • Number of Products by Top 10 Mechanism of Actions, H2 2014
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014
  • Number of Products by Top 10 Routes of Administration, H2 2014
  • Number of Products by Stage and Top 10 Routes of Administration, H2 2014
  • Number of Products by Top 10 Molecule Types, H2 2014
  • Number of Products by Stage and Top 10 Molecule Types, H2 2014
Back to Top